REGN |
REGENERON PHARMACEUTICALS, INC. |
Feb 26, 2024 |
1 |
0 |
4 |
Feb 28, 2024 |
EVP Research and Development |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Feb 7, 2024 |
7 |
-7,637,954 |
4 |
Feb 8, 2024 |
EVP Research and Development |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Feb 2, 2024 |
3 |
-9,438,846 |
4 |
Feb 6, 2024 |
EVP Research and Development |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Dec 8, 2023 |
4 |
-1,294,591 |
4 |
Dec 12, 2023 |
EVP Research and Development |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Nov 10, 2023 |
1 |
0 |
4 |
Nov 14, 2023 |
EVP Research and Development |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Aug 21, 2023 |
6 |
-21,775,088 |
4 |
Aug 23, 2023 |
EVP Research and Development |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Dec 16, 2022 |
2 |
0 |
4 |
Dec 20, 2022 |
EVP Research and Development |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Dec 9, 2022 |
2 |
-351,028 |
4 |
Dec 13, 2022 |
EVP Research and Development |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Aug 4, 2022 |
20 |
-32,534,918 |
4 |
Aug 8, 2022 |
EVP Research and Development |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Dec 11, 2021 |
1 |
-500,248 |
4 |
Dec 14, 2021 |
EVP Research and Development |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Dec 8, 2021 |
2 |
0 |
4 |
Dec 10, 2021 |
EVP Research and Development |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Dec 3, 2021 |
5 |
-18,858,197 |
4 |
Dec 6, 2021 |
EVP Research and Development |
REGN |
REGENERON PHARMACEUTICALS, INC. |
May 14, 2021 |
10 |
-19,359,184 |
4 |
May 18, 2021 |
EVP Research and Development |